Your browser doesn't support javascript.
loading
Population Pharmacokinetics of Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, and Ribavirin in Hepatitis C Virus-Infected Cirrhotic and Non-cirrhotic Patients: Analyses Across Nine Phase III Studies.
Gopalakrishnan, Sathej; Mensing, Sven; Menon, Rajeev M; Zha, Jiuhong.
Afiliación
  • Gopalakrishnan S; Clinical Pharmacology and Pharmacometrics, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany.
  • Mensing S; Clinical Pharmacology and Pharmacometrics, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany.
  • Menon RM; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., Building AP31-3, 1 North Waukegan Rd., North Chicago, IL, 60064, USA.
  • Zha J; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., Building AP31-3, 1 North Waukegan Rd., North Chicago, IL, 60064, USA. jiuhong.zha@abbvie.com.
Clin Pharmacokinet ; 57(11): 1407-1419, 2018 11.
Article en En | MEDLINE | ID: mdl-29516428

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C / Cirrosis Hepática Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacokinet Año: 2018 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Hepatitis C / Cirrosis Hepática Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacokinet Año: 2018 Tipo del documento: Article País de afiliación: Alemania